Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BAXTER INTERNATIONAL INCBAX · Entity 1707 | EVP,Group Pres,Healthcare | March 06, 2026 | March 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BAXTER INTERNATIONAL INC
Report date March 06, 2026 · Filed March 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1 par valueSEC Table I · non-derivative | Direct | 125,557 |
Reported balance
After 2026-03-06 transaction · row 1
1 source rowRow 1 · 2026-03-06 · Tax withholding · Disposed 12,674 · Balance 125,557 F1: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2026 Filed Mar 10, 2026 20:06 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 12,674 | $17.69 | $224,203.06 |
DisclosureSEC source: 0001628280-26-016405 · wk-form4_1773173171.xml · nonDerivative · entry 1 Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,557 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 00:09 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 1,614 | $19.69 | $31,779.66 |
DisclosureSEC source: 0001628280-26-014243 · wk-form4_1772582952.xml · nonDerivative · entry 1 Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,231 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 00:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 5,770 | $21.73 | $125,382.10 |
DisclosureSEC source: 0001628280-26-007416 · wk-form4_1770854931.xml · nonDerivative · entry 2 Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,846 F2 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs. F3 · balance_after: Total includes the automatic reinvestment of dividends. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 00:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 18,951 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-007416 · wk-form4_1770854931.xml · nonDerivative · entry 1 Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,616 F1 · shares: Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:05 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 87,417 | $0.00 Strike: $35.44 | $0.00 |
DisclosureSEC source: 0001062993-25-005026 · form4.xml · derivative · entry 3 Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,417 Underlying: Common Stock, $1 par value · 87,417 shares Expires 2035-03-06 F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:05 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 26,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005026 · form4.xml · nonDerivative · entry 2 Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,614 F2 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:05 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 9,341 | $35.44 | $331,045.04 |
DisclosureSEC source: 0001062993-25-005026 · form4.xml · nonDerivative · entry 1 Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,394 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2025 from the settlement of vested restricted stock units granted on March 6, 2024. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:04 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 1,987 | $34.86 | $69,266.82 |
DisclosureSEC source: 0001062993-25-004533 · form4.xml · nonDerivative · entry 1 Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,735 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 3, 2025 from the settlement of vested restricted stock units granted on March 2, 2022 and March 1, 2023. F2 · balance_after: Total includes the automatic reinvestment of dividends. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:11 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 2,032 | $33.55 | $68,173.60 |
DisclosureSEC source: 0001062993-24-020053 · form4.xml · nonDerivative · entry 1 Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,116 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on December 2, 2024 from the settlement of vested restricted stock units granted on December 1, 2021. F2 · balance_after: Total includes the automatic reinvestment of dividends. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:10 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 83,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005963 · form4.xml · nonDerivative · entry 1 Rasul Reazur · CIK 0001967379 · EVP,Group Pres, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,187 F1 · shares: For 2024, the annual equity grant for the reporting person consisted solely of restricted stock units (RSUs). The reporting person received a grant of RSUs which are scheduled to vest in three equal annual installments beginning on March 6, 2025, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:04 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 522 | $42.50 | $22,185.00 |
DisclosureSEC source: 0001062993-24-005677 · form4.xml · nonDerivative · entry 1 Rasul Reazur · CIK 0001967379 · EVP, Group Pres, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,834 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 4, 2024 from the settlement of vested restricted stock units granted on March 2, 2022 and March 3, 2021. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:16 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 1,538 | $41.01 | $63,073.38 |
DisclosureSEC source: 0001062993-24-005493 · form4.xml · nonDerivative · entry 1 Rasul Reazur · CIK 0001967379 · EVP, Group Pres, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,357 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 1, 2024 from the settlement of vested restricted stock units granted on March 1, 2023. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:58 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 248 | $40.31 | $9,996.88 |
DisclosureSEC source: 0001062993-24-003180 · form4.xml · nonDerivative · entry 2 Rasul Reaz · CIK 0001967379 · EVP, Group Pres, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,895 F2 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2021 PSUs. F3 · balance_after: Total includes the automatic reinvestment of dividends. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:58 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 716 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-003180 · form4.xml · nonDerivative · entry 1 Rasul Reaz · CIK 0001967379 · EVP, Group Pres, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,143 F1 · shares: Represents shares awarded from the performance share unit award granted on March 3, 2021 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2021 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2021 to December 31, 2023 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended. Read SEC document |
| March 20, 2023 Filed Mar 22, 2023 20:04 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 151 | $38.19 | $5,766.69 |
DisclosureSEC source: 0001062993-23-007481 · form4.xml · nonDerivative · entry 1 Rasul Reaz · CIK 0001967379 · EVP, Group Pres, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,765 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 20, 2023 from the settlement of vested restricted stock units granted on March 20, 2020. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:13 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 148 | $39.94 | $5,911.12 |
DisclosureSEC source: 0001062993-23-006172 · form4.xml · nonDerivative · entry 1 Rasul Reaz · CIK 0001967379 · EVP, Group Pres, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,917 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 3, 2023 from the settlement of vested restricted stock units granted on March 3, 2021. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:13 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 416 | $39.62 | $16,481.92 |
DisclosureSEC source: 0001062993-23-006068 · form4.xml · nonDerivative · entry 1 Rasul Reaz · CIK 0001967379 · EVP, Group Pres, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,066 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2023 from the settlement of vested restricted stock units granted on March 2, 2022. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:10 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 63,965 | $0.00 Strike: $39.06 | $0.00 |
DisclosureSEC source: 0001062993-23-005862 · form4.xml · derivative · entry 2 Rasul Reaz · CIK 0001967379 · EVP, Group Pres, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,965 Underlying: Common Stock, $1 par value · 63,965 shares Expires 2033-03-01 F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:10 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 15,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005862 · form4.xml · nonDerivative · entry 1 Rasul Reaz · CIK 0001967379 · EVP, Group Pres, Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,482 F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.